Holmium Laser Ablation of the Prostate (HoLAP) is a safe and effective BPH treatment option that provides immediate symptom relief with few complications.

The holmium laser penetrates just enough to precisely and quickly vaporize tissue without causing deeper thermal injury, coagulation necrosis or collateral damage.

HoLAP is a virtually bloodless, out-patient procedure that offers quick recovery time and a rapid return to normal activity.

HoLAP is durable at 7 years ¹

• Durable outcomes over 7 years
• 47% decrease in AUA symptom score
• 83% improvement in flow rate
• 15% reoperation rate comparable to TURP

HoLAP results are comparable to TURP ²

• HoLAP and TURP outcomes equivalent at 12 months
• Catheterization times for HoLAP shorter than TURP
• Hospital stay for HoLAP shorter than TURP
• No post-operative irrigation required with HoLAP
• No initial dysuria
  
  

Holmium versus PVP at 12 months ^2,3,4

• Holmium has fewer overall complications compared to PVP
• Holmium has significantly lower rate of dysuria compared to PVP
• Holmium has minimal transfusion risk and no cases of TUR syndrome

High power holmium ideal for BPH

The holmium laser penetrates just enough to precisely and quickly vaporize tissue without causing deeper thermal injury, coagulation necrosis or collateral damage.

1. Tan A, et al. Long-term Results of High-power Holmium Laser Vaporization (Ablation) of the Prostate., BJU International, 92:707-9, 2003
2. Mottet N, et al. Randomized Comparison of Transurethral Electroresection of Holmium:YAG Laser Vaporization for Symptomatic Benign Hyperplaysia. J Endo, 13:127-120, Mar 1999
3. Kruntz RM. Current Role of Lasers in the Treatment of Benign Prostatic Hyperplasia. Eur Urol, 49:961-969, Jun 2006
4. Gilling, et al. Use of Holmium Laser in the Treatment of Benign Prostatic Hyperplasia. J Endo, 10(5):459-461, Oct 1996

PB-1116830_A